Consistent with previous reports, the immune-high subtype is characterized by poorly differentiated HCC, positive for CK19 and/or Sal-like protein 4 (SALL4), and enrichment of tumors belonging to S1 and G2 subclasses (Figure 1) [34,38]. This evidence concerns the gene KRT19 and hepatocellular carcinoma.